Overview of otolaryngic allergy management: An eclectic and cost- effective approach

Otolaryngologic Clinics of North America

Volumn 31, Issue 1, 1998, Pages 69-82

  Hadley, J A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BROMPHENIRAMINE; BUDESONIDE; CHLORPHENIRAMINE; CHLORPHENIRAMINE MALEATE; CROMOGLYCATE DISODIUM; DIPHENHYDRAMINE; FLUNISOLIDE; FLUTICASONE; LORATADINE; STEROID; TERFENADINE; TRIAMCINOLONE ACETONIDE;

ALLERGIC RHINITIS; ALLERGY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CYTODIAGNOSIS; DRUG COST; HAY FEVER; HEALTH CARE COST; HEALTH CARE DELIVERY; IMMUNOTHERAPY; MANAGED CARE; QUALITY OF LIFE; REVIEW; SKIN TEST;

EID: 0031934878     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(05)70030-X     Document Type: Article

References (20)

1. A.C. Enthoven Market forces and health care costs JAMA 266 1991 2751 2752
2. Fell WR, Mabry RL, Mabry CS: Cost-benefit analysis of immunotherapy for allergic rhinitis. Presented at American Academy of Otolaryngic Allergy Annual Meeting. September 27, 1996, in press
3. J.A. Fornadley J.P. Corey J.D. Osguthorpe Allergic rhinitis: Clinical practice guideline Otolaryngol Head Neck Surg 115 1996 115 121
4. J.F. Fries C.E. Koop C.E. Beadle Reducing health-care costs by reducing the need and demand for medical services: The Health Care Project Consortium N Engl J Med 329 1993 321 325
5. R. Glicklich R. Metson The health impact of chronic sinusitis in patients seeking otolaryngic care Otolaryngol Head Neck Surg 113 1995 104 109
6. E.F. Juniper G.H. Guyatt Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 21 1991 77 83
7. E.F. Juniper G.H. Guyatt J. Dolovich Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials J Allergy Clin Immunol 93 1994 413 423
8. J.P. Keenan Office examination of the allergic patient H.F. Krause Otolaryngic Allergy and Immunotherapy 1989 WB Saunders Co Philadelphia 93 111
9. H.C. King Skin endpoint titration: Still the standard? Otolaryngol Clin North Am 25 1992 13 25
10. W.P. King Efficacy of a screening radioallergosorbent test Arch Otolaryngol Head Neck Surg 108 1982 781 786
11. H.F. Krause Nasal cytology in clinical allergy H.F. Krause Otolaryngic Allergy and Immunology 1989 WB Saunders Co Philadelphia 112 122
12. V.J. Lund J. Aaronson J. Bosquet International consensus report on the diagnosis and management of rhinitis Allergy 49 1994 5 34
13. R.L. Mabry Blending skin endpoint titration and in vitro methods in clinical practice Otolaryngol Clin North Am 25 1992 61 70
14. P. McMenamin Costs of hay fever in the United States in 1990 Ann Allergy 73 1994 35 39
15. D. McTavish E.M. Sorkin Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential Drugs 38 1989 778 800
16. E.O. Meltzer An overview of current pharmacotherapy in perennial rhinitis J Allergy Clin Immunol 95 1995 1097 1110
17. R.M. Naclerio Allergic rhinitis N Engl J Med 325 1991 860 869
18. Nalebuff DJ: Use of RAST screening in clinical allergy: A cost-effective approach to patient care. Ear Nose Throat J 64:107–121
19. B. Sibbald E. Rink Epidemiology of seasonal and perennial rhinitis: Clinical presentation and medical history Thorax 46 1991 895 901
20. J.W. Willoughby New concepts in immunotherapy Otolaryngol Clin North Am 25 1992 71 100